Annual report pursuant to Section 13 and 15(d)

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

12 Months Ended

Dec. 31, 2021

Prepaid Expense And Other Assets Current [Abstract]

Prepaid Expenses and Other Current Assets

(5)	Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

		December 31, 2021				December 31, 2020
Research and development tax credit receivable		$	840			$	801
Prepaid insurance			624				415
Interest receivable			290				—
Value added tax receivable			75				64
Other prepaid assets			56				231
Short-term deposits			37				2,360
Refundable FDA filing fee (1)			—				2,876
Prepaid research and development expenses			—				157
Total		$	1,922			$	6,904
(1) FDA filing fee refund of $2,876 was received in January 2021